Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries

Journal of Steroid Biochemistry and Molecular Biology

Volumn 159, Issue , 2016, Pages 73-85

  Dikshit, Anushka ^a   Gao, Chunqi ^a   Small, Carrie ^a   Hales, Karen ^a   Hales, Dale Buchanan ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Flaxseed; Hen; Ovarian cancer

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; AROMATASE; CATECHOL METHYLTRANSFERASE; CRK ASSOCIATED SUBSTRATE PROTEIN; CYTOCHROME P450 1A1; ENTERODIOL; ENTEROLACTONE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN C FOS; PROTEIN KINASE B BETA; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; TRANSCRIPTION FACTOR MAFF; 2-METHOXYESTRADIOL; AVIAN PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; LINSEED OIL; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; ESTROGEN METABOLISM; FEMALE; GLUCOSE HOMEOSTASIS; HEN; LINSEED; NONHUMAN; OVARY; OVARY CANCER; PRECANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; CHICKEN; DIET THERAPY; DIETARY SUPPLEMENT; ENZYMOLOGY; FLAX; GENE EXPRESSION; LIVER; METABOLISM; OVARIAN NEOPLASMS; VETERINARY;

ANIMALS; AVIAN PROTEINS; CHICKENS; CYTOCHROME P-450 CYP1A1; DIETARY SUPPLEMENTS; ESTRADIOL; FEMALE; FLAX; GENE EXPRESSION; LINSEED OIL; LIVER; NF-KAPPA B; OVARIAN NEOPLASMS; OVARY; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84959543526     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.02.028     Document Type: Article

References (89)

1. P. Ganorkar, and R. Jain Flaxseed-a nutritional punch Int. Food Res. J. 20 2013 519 525
2. A. Touré, and X. Xueming Flaxseed lignans: source, biosynthesis, metabolism, antioxidant activity, bio-active components, and health benefits Compr. Rev. Food Sci. Food Saf. 9 2010 261 269
3. D.H. Morris Flax: A Health and Nutrition Primer 2007 Flax Council of Canada
4. S.C. Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clin. Nutr. 79 2004 935 945
5. T.H. Lee, R.L. Hoover, J.D. Williams, R.I. Sperling, J. Ravalese III, B.W. Spur, D.R. Robinson, E. Corey, R.A. Lewis, and K.F. Austen Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function New Engl. J. Med. 312 1985 1217 1224
6. J.M. Kremer, D.A. Lawrence, and W. Jubiz Different doses of fish-oil fatty acid ingestion in active rheumatoid arthritis: a prospective study of clinical and immunological parameters, dietary ω3 and ω6 fatty acids Springer 2016 343 350
7. J.S. Charnock Antiarrhythmic effects of fish oils World Rev. Nutr. Diet 66 1991 278 291
8. U. Barcelli, P. Glas-Greenwalt, and V.E. Pollak Enhancing effect of dietary supplementation with ω-3 fatty acids on plasma fibrinolysis in normal subjects Thromb. Res. 39 1985 307 312
9. H. Davis, R. Bridenstine, D. Vesselinovitch, and R. Wissler Fish oil inhibits development of atherosclerosis in rhesus monkeys Arterioscler. Thromb. Vasc. Biol. 7 1987 441 449
10. T. Sanders, and M.C. Hochland A comparison of the influence on plasma lipids and platelet function of supplements of ω3 and ω6 polyunsaturated fatty acids Br. J. Nutr. 50 1983 521 529
11. K. Prasad Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed Mol. Cell. Biochem. 168 1997 117 123
12. S.O. Mueller, S. Simon, K. Chae, M. Metzler, and K.S. Korach Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells Toxicol. Sci. 80 2004 14 25
13. W. Zhang, X. Wang, Y. Liu, H. Tian, B. Flickinger, M.W. Empie, and S.Z. Sun Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia J. Med. Food 11 2008 207 214
14. S. Fukumitsu, K. Aida, H. Shimizu, and K. Toyoda Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men Nutr. Res. 30 2010 441 446
15. K. Neukam, S. De Spirt, W. Stahl, M. Bejot, J. Maurette, H. Tronnier, and U. Heinrich Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition Skin Pharmacol. Physiol. 24 2010 67 74
16. L.U. Thompson, J.M. Chen, T. Li, K. Strasser-Weippl, and P.E. Goss Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer Clin. Cancer Res. 11 2005 3828 3835
17. A. Dikshit, M.A. Gomes Filho, E. Eilati, S. McGee, C. Small, C. Gao, T. Klug, and D.B. Hales Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner Br. J. Nutr. 2015 1 12
18. C.J. Haggans, A.M. Hutchins, B.A. Olson, W. Thomas, M.C. Martini, and J.L. Slavin Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women Nutr. Cancer 33 1999 188 195
19. M.B. Jungeström, L.U. Thompson, and C. Dabrosin Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo Clin. Cancer Res. 13 2007 1061 1067
20. J. Chen, E. Hui, T. Ip, and L.U. Thompson Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice Clin. Cancer Res. 10 2004 7703 7711
21. J. Chen, P.M. Stavro, and L.U. Thompson Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor Nutr. Cancer 43 2002 187 192
22. W. Demark-Wahnefried, T.J. Polascik, S.L. George, B.R. Switzer, J.F. Madden, M.T. Ruffin, D.C. Snyder, K. Owzar, V. Hars, and D.M. Albala Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery Cancer Epidemiol. Biomarkers Prev. 17 2008 3577 3587
23. W. Demark-Wahnefried, D.T. Price, T.J. Polascik, C.N. Robertson, E.E. Anderson, D.F. Paulson, P.J. Walther, M. Gannon, and R.T. Vollmer Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features Urology 58 2001 47 52
24. L. Yan, J.A. Yee, D. Li, M.H. McGuire, and L.U. Thompson Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice Cancer Lett. 124 1998 181 186
25. E. Eilati, J.M. Bahr, and D.B. Hales Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E2 in hens Gynecol. Oncol. 3 2013 620 628
26. K. Ansenberger, Y. Zhuge, C. Richards, A. Barua, J.L. Luborsky, J.M. Bahr, and D.B. Hales Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed enriched diet for one year Gynecol. Oncol. 117 2010 341 347
27. 2 in laying hen ovaries Prostag. Leukotr. Ess. Fatty Acids (PLEFA) 89 2013 179 187
28. A. Simopoulos Human requirement for N-3 polyunsaturated fatty acids Poult. Sci. 79 2000 961 970
29. E. Eilati, C.C. Small, S.R. McGee, N.K. Kurrey, and D.B. Hales Anti-inflammatory effects of fish oil in ovaries of laying hens target prostaglandin pathways Lipids Health Dis. 12 2013 152
30. K. Ansenberger, Y. Zhuge, J.A. Lagman, C. Richards, A. Barua, J.M. Bahr, and D.B. Hales E-cadherin expression in ovarian cancer in the laying hen Gallus domesticus, compared to human ovarian cancer Gynecol. Oncol. 113 2009 362 369
31. K.H. Hales, S.C. Speckman, N.K. Kurrey, and D.B. Hales Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancer BMC Genomics 15 2014 709
32. M.A. Spillman, N.G. Manning, W.W. Dye, C.A. Sartorius, M.D. Post, J.C. Harrell, B.M. Jacobsen, and K.B. Horwitz Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis Cancer Res. 70 2010 8927 8936
33. Y. Zhuge, J.A.J. Lagman, K. Ansenberger, C.J. Mahon, T. Daikoku, S.K. Dey, J.M. Bahr, and D.B. Hales CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus Gynecol. Oncol. 112 2009 171 178
34. E. Eilati, L. Pan, J.M. Bahr, and D.B. Hales Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens Prostag. Leukotr. Ess. Fatty Acids 87 2012 177 184
35. E. Eilati, K. Hales, Y. Zhuge, K. Ansenberger Fricano, R. Yu, R.B. van Breemen, and D. Buchanan Hales Flaxseed enriched diet-mediated reduction in ovarian cancer severity is correlated to the reduction of prostaglandin E2 in laying hen ovaries Prostag. Leukotr. Ess. Fatty Acids (PLEFA) 89 2013 179 187
36. T. Fostis, Y. Zhang, M. Pepper, H. Adlercreutz, R. Montesano, P. Nawroth, and L. Schweigere The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogensin and suppresses tumor growth Nature 17 1994 237 239
37. F.F. Parl Estrogens, Estrogen Receptor, and Breast Cancer 2000 Ios Press
38. J.C. Seegers, M.-L. Lottering, C.J. Grobler, D.H. van Papendorp, R.C. Habbersett, Y. Shou, and B.E. Lehnert The mammalian metabolite 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells J. Steroid Biochem. Mol. Biol. 62 1997 253 267
39. Y.S. Chua, Y.L. Chua, and T. Hagen Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity Mol. Cancer Ther. 9 2010 224 235
40. B.T. Zhu, and A.H. Conney Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58 1998 2269 2277
41. J.G. Liehr, and M.J. Ricci 4-Hydroxylation of estrogens as marker of human mammary tumors Proc. Natl. Acad. Sci. 93 1996 3294 3296
42. H. Bradlow, R. Hershcopf, C. Martucci, and J. Fishman 16α-Hydroxylation of estradiol: a possible risk marker for Breast cancer Ann. N.Y. Acad. Sci. 464 1986 138 151
43. Y. Amakura, T. Tsutsumi, M. Nakamura, H. Kitagawa, J. Fujino, K. Sasaki, M. Toyoda, T. Yoshida, and T. Maitani Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay Biol. Pharm. Bull. 26 2003 532 539
44. S. Kress, and W.F. Greenlee Cell-specific regulation of human CYP1A1 and CYP1B1 genes Cancer Res. 57 1997 1264 1269
45. D.C. Spink, B.C. Spink, J.Q. Cao, J.A. DePasquale, B.T. Pentecost, M.J. Fasco, Y. Li, and T.R. Sutter Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells Carcinogenesis 19 1998 291 298
46. C.T. Tiong, C. Chen, S.J. Zhang, J. Li, A. Soshilov, M.S. Denison, L.S.-U. Lee, V.H. Tam, S.P. Wong, and H.E. Xu A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein Carcinogenesis 33 2012 1089 1097
47. F. Frasca, G. Pandini, R. Vigneri, and I.D. Goldfine Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells Breast Dis. 17 2002 73 89
48. D. Sachdev Regulation of breast cancer metastasis by IGF signaling J. Mammary Gland Biol. Neoplasia 13 2008 431 441
49. J.M. Weiss, W.Y. Huang, S. Rinaldi, T.R. Fears, N. Chatterjee, D. Chia, E.D. Crawford, R. Kaaks, and R.B. Hayes IGF-1 and IGFBP-3: risk of prostate cancer among men in the prostate, lung, colorectal and ovarian cancer screening trial Int. J. Cancer 121 2007 2267 2273
50. D. Sachdev, and D. Yee Disrupting insulin-like growth factor signaling as a potential cancer therapy Mol. Cancer Ther. 6 2007 1 12
51. W.H. Gotlieb, I. Bruchim, J. Gu, Y. Shi, A. Camirand, M.-J. Blouin, Y. Zhao, and M.N. Pollak Insulin-like growth factor receptor I targeting in epithelial ovarian cancer Gynecol. Oncol. 100 2006 389 396
52. M. Sheikh, Z. Shao, A. Hussain, J. Chen, C. Roberts, D. LeRoith, and J. Fontana Retinoic acid and estrogen modulation of insulin-like growth factor binding protein-4 gene expression and the estrogen receptor status of human breast carcinoma cells Biochem. Biophys. Res. Commun. 193 1993 1232 1238
53. S.E. Pratt, and M.N. Pollak Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media Cancer Res. 53 1993 5193 5198
54. H. Wang, D.G. Rosen, H. Wang, G.N. Fuller, W. Zhang, and J. Liu Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types Mod. Pathol. 19 2006 1149 1156
55. A.L. Simons, K.P. Orcutt, J.M. Madsen, P.M. Scarbrough, and D.R. Spitz The role of Akt pathway signaling in glucose metabolism and metabolic oxidative stress, oxidative stress in cancerbiology and therapy Springer 2012 21 46
56. A. Makker, M.M. Goel, and A.A. Mahdi PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update J. Mol. Endocrinol. 3 2014 R103 R118
57. B. Djordjevic, B.T. Hennessy, J. Li, B.A. Barkoh, R. Luthra, G.B. Mills, and R.R. Broaddus Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing Mod. Pathol. 25 2012 699 708
58. Y.-M. Lin, B.K. Velmurugan, Y.-L. Yeh, C.C. Tu, T.-J. Ho, T.Y. Lai, C.-H. Tsai, F.J. Tsai, C.-H. Tsai, and C.-Y. Huang Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma Oncol. Rep. 30 2013 3027 3031
59. C.M. Komar Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling Reprod. Biol. Endocrinol. 3 2005 41
60. P. Li, W. Fan, J. Xu, M. Lu, H. Yamamoto, J. Auwerx, D.D. Sears, S. Talukdar, D. Oh, and A. Chen Adipocyte NCoR knockout decreases PPAR γ phosphorylation and enhances PPAR γ activity and insulin sensitivity Cell 147 2011 815 826
61. F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R.M. De Oliveira, M. Leid, M.W. McBurney, and L. Guarente Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ Nature 429 2004 771 776
62. A. Sakamoto, Y. Yokoyama, M. Umemoto, M. Futagami, T. Sakamoto, X. Bing, and H. Mizunuma Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours Br. J. Cancer 91 2004 633 638
63. E.B. Berry, J.A. Keelan, R.J. Helliwell, R.S. Gilmour, and M.D. Mitchell Nanomolar and micromolar effects of 15-deoxy-δ12, 14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors γ and δ and nuclear factor κB Mol. Pharmacol. 68 2005 169 178
64. P.A. Baeuerle, and D. Baltimore I kappa B. A specific inhibitor of the NF-kappa B transcription factor Science 242 1988 540 546
65. S.D. Catz, and J.L. Johnson Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer Oncogene 20 2001 7342 7351
66. B. Bisaro, M. Montani, G. Konstantinidou, C. Marchini, L. Pietrella, M. Iezzi, M. Galiè, F. Orso, A. Camporeale, and S.M. Colombo p130Cas/cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells Breast Cancer Res. 14 2012 137
67. S. Van Der Flier, A. Brinkman, M.P. Look, E.M. Kok, M.E. Meijer-van Gelder, J.G. Klijn, L.C. Dorssers, and J.A. Foekens Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment J. Natl. Cancer Inst. 92 2000 120 127
68. J. Huan, L. Wang, L. Xing, X. Qin, L. Feng, X. Pan, and L. Zhu Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-estradiol (E2) Gene 533 2014 346 355
69. M. Pavlovic, A. Arnal-Estapé, F. Rojo, A. Bellmunt, M. Tarragona, M. Guiu, E. Planet, X. Garcia-Albéniz, M. Morales, and J. Urosevic Enhanced MAF oncogene expression and breast cancer bone metastasis J. Natl. Cancer Inst. 107 2015 djv256
70. E.M. Hurt, A. Wiestner, A. Rosenwald, A. Shaffer, E. Campo, T. Grogan, P.L. Bergsagel, W.M. Kuehl, and L.M. Staudt Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma Cancer Cell 5 2004 191 199
71. S. Mahner, C. Baasch, J. Schwarz, S. Hein, L. Wölber, F. Jänicke, and K. Milde-Langosch C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma Br. J. Cancer 99 2008 1269 1275
72. T. Yoshimaru, M. Komatsu, E. Tashiro, M. Imoto, H. Osada, Y. Miyoshi, J. Honda, M. Sasa, and T. Katagiri Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions Sci. Rep. 4 2014
73. T. Yoshimaru, M. Komatsu, T. Matsuo, Y.-A. Chen, Y. Murakami, K. Mizuguchi, E. Mizohata, T. Inoue, M. Akiyama, and R. Yamaguchi Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells Nat. Commun. 4 2013
74. V. Appierto, M. Villani, E. Cavadini, R. Lotan, C. Vinson, and F. Formelli Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells Cell Death Differ. 11 2003 270 279
75. J.B. Welsh, P.P. Zarrinkar, L.M. Sapinoso, S.G. Kern, C.A. Behling, B.J. Monk, D.J. Lockhart, R.A. Burger, and G.M. Hampton Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Proc. Natl. Acad. Sci. 98 2001 1176 1181
76. I. Meinhold-Heerlein, D. Bauerschlag, F. Hilpert, P. Dimitrov, L.M. Sapinoso, M. Orlowska-Volk, T. Bauknecht, T.-W. Park, W. Jonat, and A. Jacobsen Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential Oncogene 24 2004 1053 1065
77. L. Oliveira-Ferrer, K. Rößler, V. Haustein, C. Schröder, D. Wicklein, D. Maltseva, N. Khaustova, T. Samatov, A. Tonevitsky, and S. Mahner c-FOS suppresses ovarian cancer progression by changing adhesion Br. J. Cancer 110 2013 753 763
78. S. Banerjee, N. Saxena, K. Sengupta, O. Tawfik, M.S. Mayo, and S.K. Banerjee WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation Neoplasia 5 2003 63 73
79. M. Akkiprik, Y. Feng, H. Wang, K. Chen, L. Hu, A. Sahin, S. Krishnamurthy, A. Ozer, X. Hao, and W. Zhang Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer Breast Cancer Res. 10 2008 212
80. H. Miyake, M. Pollak, and M.E. Gleave Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models Cancer Res. 60 2000 3058 3064
81. B.S. Stolf, A.F. Carvalho, W.K. Martins, F.B. Runza, M. Brun, R. Hirata, E.J. Neves, F.A. Soares, J. Postigo-Dias, and L.P. Kowalski Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas Cancer Lett. 191 2003 193 202
82. A. Doi, K. Ishikawa, N. Shibata, E. Ito, J. Fujimoto, M. Yamamoto, H. Shiga, H. Mochizuki, Y. Kawamura, and N. Goshima Enhanced expression of retinoic acid receptor alpha induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures Mol. Oncol. 2014
83. L. Qin, Y.-L. Wu, M.J. Toneff, D. Li, L. Liao, X. Gao, F.T. Bane, J.C. Tien, Y. Xu, and Z. Feng NCOA1 directly targets M-CSF1 expression to promote breast cancer metastasis Cancer Res. 74 13 2016 3477 3488
84. C.A. Walsh, J.C. Bolger, C. Byrne, S. Cocchiglia, Y. Hao, A. Fagan, L. Qin, A. Cahalin, D. McCartan, and M. McIlroy Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis Cancer Res. 74 2014 2533 2544
85. L. Zhang, C. Gong, S.L. Lau, N. Yang, O.G. Wong, A.N. Cheung, J.W. Tsang, K.Y. Chan, and U.-S. Khoo SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERα transcriptional activity Cancer Res. 73 2013 246 255
86. J.K. Blackmore, S. Karmakar, G. Gu, V. Chaubal, L. Wang, W. Li, and C.L. Smith The SMRT coregulator enhances growth of estrogen receptor-α-Positive Breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis Endocrinology 155 2014 3251 3261
87. S. Braig, S. Wallner, B. Junglas, R. Fuchshofer, and A. Bosserhoff CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration Br. J. Cancer 105 2011 231 238
88. Y. Zhen, Y. Ye, X. Yu, C. Mai, Y. Zhou, Y. Chen, H. Yang, X. Lyu, Y. Song, and Q. Wu Reduced CTGF expression promotes cell growth migration and invasion in nasopharyngeal carcinoma PLoS One 8 6 2013 e64976
89. K. Reiss, L. Del Valle, A. Lassak, and J. Trojanek Nuclear IRS-1 and cancer J. Cell. Physiol. 227 2012 2992 3000